Pharma stocks to buy: Cipla, Lupin, among 5 stocks with upside potential of up to 12%

Nifty Pharma index has moved in tandem with the headline index, with nearly 5% returns in the last month, with stocks gaining by up to 22% in this period. Decoding the charts, Nilesh Jain, Head Vice President, Equity Research, Technical and Derivatives at Centrum Broking, said that the CNX PHARMA index has formed an inverse head & shoulder pattern where the neckline is placed near 22,028 levels. A break above 22,200 will add further bullishness for the 22,500-22,800 level, while support is near 21550. Here are 5 stocks to buy from various brokerages: Pharma Picks